Arjan Diepstra

47PUBLICATIONS
169CO-AUTHORS
Predictive and prognostic markersMedical virologyCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (47)

|Oct 08, 2026
Immunohistochemistry for c-MET, HLA class II, and CD68 does not show prognostic value in early-stage classic Hodgkin lymphoma patients in the EORTC-GELA H9 intergroup randomised trial.

|Aug 26, 2026
Molecular profiling and disease tracking of posttransplant lymphoproliferative disorders using cell-free DNA.

|Mar 28, 2026
Relevance of Epstein-Barr Virus (EBV) miRNAs in EBV-Infected B Cells and B-Cell Lymphomas.

Nohora Juliana Rueda-Forero, Joost Kluiver, Marije Koning

|Feb 04, 2026
Impact of rituximab maintenance on survival in patients with mantle cell lymphoma: a population-based cohort study.

Floriske G Stedema, Mirian Brink, Francien Huisman

|Nov 25, 2025
Whole-body CD8+ T-cell PET imaging in patients with large B-cell lymphoma before and during CD19-directed CAR T-cell therapy: a phase 2 study.

Janneke W de Boer, Kylie Keijzer, Jaap A van Doesum

|Oct 29, 2025
Multi-cohort high-dimensional proteomics reveals early risk markers for lymphoid cancer subtypes.

P Martijn Kolijn, Karl Smith-Byrne, Vernon Burk

Pageof 8

Frequent Collaborators

15 joint publications

Anke van den Berg

11 joint publications

Marcel Nijland

7 joint publications

Joost S P Vermaat

6 joint publications

Wouter Plattel